Video

Dr Michael D'Angelica on the Necessity of Multidisciplinary Collaboration in Hepatobiliary Cancer

Michael I. D'Angelica, MD, FACS, of Memorial Sloan Kettering Cancer Center, discusses multidisciplinary care and why it is so important in hepatobiliary cancers.

Michael I. D'Angelica, MD, FACS, director of the Hepatopancreatobiliary Fellowship Program at Memorial Sloan Kettering Cancer Center, discusses multidisciplinary care and why it is so important in hepatobiliary cancers.

Transcript

Can you speak to the importance of multidisciplinary care in the treatment of hepatobiliary cancers?

When I think about the hepatobiliary guidelines, it really comes down to this idea that it truly has to be multidisciplinary. I think we say that for every cancer, and it's obvious that it's important. But in some cancers, it's really not as prominent as it is in hepatobiliary cancers, where you need the expertise of certain types of surgeons, transplant surgeons, surgical oncologists, or medical oncologists; but also a gastroenterologist to manage things like biliary obstruction, or interventional radiologists to perform intraarterial therapies and percutaneous ablation techniques. And again, these cancers really do require true multidisciplinary care, and i think it's critical that centers have all of this expertise if they're going to manage these cancers.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo